NCT00997464Unknown不适用
An Exploration of Factors Affecting Interest and Uptake of Genetic Testing for Prostate Cancer Susceptibility: The Clinical Application of Genetic Testing for Lower Risk Cancer Predisposition Genes
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Whether cancer worry changes between the two time-points (measured using the Impact of Event Scale)
研究概览
简要总结
Study of the factors that affect interest in - and uptake of - genetic testing for variants that predispose to prostate cancer from the perspective of the patient.
详细描述
This study will use a mixed methods approach to follow men as they move through the genetic testing process, from initial contact through to receiving their genetic testing results. A questionnaire will be used to measure variables at both baseline and after proceeding through the testing process. A small cohort of men will be invited to be interviewed to gather some in depth qualitative data about the issues that have arisen during the study process.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 40 Years 至 69 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Men with a positive family history of prostate cancer. The definition of a positive family history will be: Men with a first degree relative with prostate cancer diagnosed at <70 years; Men with two relatives with prostate cancer where at least on is diagnosed at <70 years; Men with three relatives with prostate cancer diagnosed at any age
- •Age 40-69 years
- •No previous biopsy for raised PSA
- •Absence of any psychological, familial, sociological or geographic situation potentially hampering compliance with the study protocol and follow-up schedule.
排除标准
- •Previous prostate cancer
- •Men from families where there is known to be a mutation in a high-risk prostate cancer gene
- •Men who have had a prostate biopsy within the last 12 months.
结局指标
主要结局
Whether cancer worry changes between the two time-points (measured using the Impact of Event Scale)
次要结局
- Why are men interested/ not interested in seeking genetic profiling for prostate cancer, and what might be the uptake of such testing?
- What are the expectations of this testing from the perspective of the user, what are the perceived benefits and limitations of testing and how do these change through the testing process
- Is there a relationship between a family history of cancer, cancer worry, and a persons intention to seek genetic testing?
- How would the information provided by such a test be used by the individual and the family and how could this impact upon the healthcare system
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
2 期
Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's DiseaseAlzheimer DiseaseNCT04840979Columbia University107
招募中
不适用
Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AMLLeukemia, Myeloid, AcuteNCT06580106Wake Forest University Health Sciences50
终止
不适用
Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer PatientsCancerNCT02706652National Cancer Institute (NCI)8
已完成
不适用
Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMDGenetic CounselingChoroidal NeovascularizationAge-Related Macular DegenerationNCT03024424University of Utah16
已完成
不适用
Broadening the Reach, Impact, and Delivery of Genetic ServicesRisk Reduction BehaviorCancerNCT03985852University of Utah3,073